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The endocrine system in higher mammals represents one of
the most complex and fundamental systems that regulates
nearly all of an organism’s biological functions. This system is
composed of multiple organs, tissues, hormones, and recep-
tor modalities. Its ability to regulate critical functions such
as reproduction, development, metabolism, stress responses,
blood pressure, wakefulness, and digestion places it as one
of the most important regulators of life-long physiology.
Therefore, at any one point in time the physiological status
of the majority of organs in the body is a function of the
activity of the whole endocrine system. However, while
appreciating the role of the endocrine system in such “fro-
zen” points in time is important, the temporal variation
in endocrine function across one’s lifespan is of crucial
interest to researchers investigating age-related disorders.
The importance of gerontological research is becoming more
and more evident, given the ever-increasing proportion of
aged people in Western countries.
Aging is a natural process that involves a general decline
in many physiological functions with time. Aging is generi-
cally associated with a reduced capacity to maintain home-
ostasis and eﬀective repair mechanisms, resulting in loss
of function, senescence, and eventually death. It is obvious
that the functions of endocrine organs alter during the
aging process, resulting in a higher prevalence of endocrine
malfunction-related disorders in the elderly population.
Enhanced knowledge and appreciation of endocrine func-
tions in aging will likely lead to the development of successful
pharmacological or lifestyle therapies to treat endocrine-
related diseases in elderly patients. The discovery and devel-
opment of novel endocrine-targeted remedies will hopefully
result in an improvement of quality of life and also overall
lifespan. Thus, endocrine functions in the aging context are
important fields of intense clinical and scientific interest and
form the focus of this special issue.
The papers in this special issue are focused upon original
research papers and review papers concerning several impor-
tant molecular and tissue systems vital to the maintenance
of the endocrine system in aging, that is, pancreatic function
and type 2 diabetes mellitus (T2DM); testosterone deficiency
and depression; metabolic and endocrine alterations in
muscle dystrophies and sarcopenia; serum adipokines and
osteocalcin in older patients with hip fracture; geronto-
logical neuroendocrine axis organization and disruption;
correlation of thyroid hormones and lipid profiles in elderly
T2DM patients; minimally invasive approaches to parathy-
roid surgery in elderly patients; the proper interpretation of
hormones and tumor marker measurements in the geriatric
population.
As we have stated, aging is an important risk factor for
metabolic disorders, including obesity, impaired glucose tol-
erance, and type 2 diabetes. Aging has long been associated
in multiple animal species with the insulin/insulin-like
growth factor-1 (IGF-1) signaling system. Z. Gong and R. H.
Muzumdar summarize in their paper the current evidence
on how aging aﬀects pancreatic β-cell function, β-cell mass,
insulin secretion, and insulin sensitivity. They also review the
eﬀects of aging on the relationship between insulin sensitivity
and insulin secretion. Accelerated insulin resistance appears
to be one of the strongest hallmarks of advanced physiolog-
ical aging; therefore, a comprehensive understanding of all
the defects that impair glucose homeostasis in the elderly
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will likely lead to the development of novel treatments that
may substantially improve life quality and lifespan.
Testosterone deficiency, or hypotestosteronemia, is a
widely recognized hormonal alteration strongly associated
with male aging. The review paper by M. Amore et al.
comprehensively summarizes the current understanding of
the correlation between depressive symptoms with a syn-
drome called partial androgen deficiency of the aging male
(PADAM). This paper highlights the potential benefits of
testosterone treatment upon mood and aﬀective disorders.
While supplementation with testosterone fails to show sound
evidence of eﬀectiveness in the treatment of depression,
testosterone supplementation has proved to be eﬀective, on
some levels, for improving quality of life of aged patients with
PADAM.
In addition to the gerontological eﬀects upon steroid
hormone activity, aging also significantly aﬀects thyroid
function. These age-related eﬀects, acting through the thy-
roid hormone system, greatly impact both lipid profiles and
somatic metabolic parameters. The study conducted by F.
Strollo et al. investigates the correlation between free thyrox-
ine (FT4), free triiodothyronine (FT3) levels and total choles-
terol (TC), and low-density lipoprotein cholesterol (LDL-C)
levels in euthyroid elderly T2DM patients. They found that
TC and LDL-C correlate negatively with FT4 and positively
with FT3. When divided according to treatment by oral
hypoglycemic agents (OHA) and insulin (IT), they, however,
reacted diﬀerently with respect to investigated associations.
Primary hyperparathyroidism (pHPT) is one of the most
common endocrine diseases in the elderly and the chance of
developing pHPT increases with age. Elderly patients with
pHPT are often not referred for surgery because of their
associated comorbidities that may increase surgical risk. The
study by C. Dobrinja et al. demonstrates that minimally
invasive approaches to parathyroid surgery seem to be safe
and curative in elderly patients, with few associated risks
because of the combination ofmodern preoperative imaging,
advances in surgical technique, and advances in anesthesia
care.
One of the most important factors related to the mainte-
nance of health and independence in the elderly is endocrine-
mediated control of the musculo skeletal system. An inability
to maintain independence as well as increased morbidity due
to elevated fall episodes are both likely to severely impact
the cost of widespread healthcare in aging Western societies.
Therefore, we have included several sections that contend
with the eﬀects of aging upon the endocrine regulation of
musculo-skeletal tissues.
Common metabolic and endocrine alterations exist
across a wide range of muscular dystrophies. The paper
by O. del Rocı´o Cruz Guzma´n et al. expertly reviews the
current knowledge concerning the metabolic and endocrine
alterations in diverse types of dystrophinopathies includ-
ing childhood and adult dystrophies. K. Sakuma and A.
Yamauchi also review the vital pieces of data concerning
our current understating of the endocrine contribution to
the age-related declines in muscle mass, muscle strength,
and sarcopenia. These authors also investigated the current
hormonal interventions designed to improve endocrine
defects related to sarcopenia. Myostatin inhibition seems
to be an intriguing strategy for attenuating sarcopenia as
well as muscular dystrophy. The authors discussed how
therapeutic supplementation with growth hormone, IGF-I,
or estrogen had a minor sarcopenia-inhibiting eﬀect, and
that testosterone supplementation in large doses had several
side eﬀects, even though it significantly improved muscle
defects. Ghrelin mimetics could also potentially be beneficial
and reverse the dysfunctional catabolic state associated with
sarcopenia in the elderly population.
Low bonemass density, a classical age-related health issue
and a known health concern for fair-skinned, thin, postme-
nopausal Caucasian women, is found to be common among
individuals with developmental/intellectual disabilities. The
review paper by J. Jasien et al. provides a comprehensive over-
view of bone health of adults with developmental/intellectual
disabilities, their risk of fractures, and how this compares
to the general aging population. The authors contend that
gaining a greater understanding of how bone health aﬀected
in individuals with developmental/intellectual disabilities
could lead to better customized treatments for these specific
populations.
The paper by A. Fisher et al. reveals the interactions
between serum adipokines and osteocalcin in older patients
with hip fracture. The authors found that serum osteocalcin
concentration was inversely associated with resistin and
positively with leptin, leptin/resistin ratio, and adiponectin/
resistin ratio after adjustment for multiple potential con-
founders. Osteocalcin was found to be an independent pre-
dictor of serum leptin, resistin, leptin/resistin, and adipone-
ctin/resistin ratios, which suggests bidirectional interactions
(crosstalk) between leptin, resistin, and osteocalcin as a part
of a complex homeostatic system regulating bone and energy
metabolism.
The accuracy of analytical measurements of diﬀerent
biochemical parameters is of vital importance for the proper
diagnosis and treatment monitoring of elderly patients. The
paper by K. Sztefko et al. discusses important points to
be considered in the interpretation of hormone and tu-
mor marker measurements in the geriatric population
using immunochemical methods, including general lack of
immunoassay standardization, presence of cross-reacting
substances in patients’ samples, limitation of free hormone
measurements due to abnormal analyte binding protein
concentrations, assay interferences due to a patient’s autoan-
tibodies, heterophilic antibodies, and proper interpretation
of very low- and very-high-sample analyte levels.
While the endocrine system is classically associated with
the regulation of autonomic hormonal functions, many lines
of recent evidence have demonstrated that cognitive central
nervous function in the elderly is significantly aﬀected
during the aging process by endocrine control of somatic
metabolism. Hence, both normal and pathophysiological
aging, as well as neurodegenerative disorders, are all influ-
enced by this “neurometabolic” interface. This functional
connection between these two important systems (neuronal
and endocrine) is primarily mediated through hormonal
communication between the brain and the metabolic organs.
The review paper by S. Siddiqui et al. discusses the physical
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structure and molecular components of this fundamental
“neurometabolic” axis in aging. The authors then elaborate
upon this by discussing how the connection of these two
major functional domains is likely to be created by multifun-
ctional “keystone” signaling factors, such as the epidermal
growth factor receptor (EGFR). This paper draws together
evidence to aid the appreciation of the truly multidimen-
sional role of EGFR, at the systemic level, in neurometabolic
processes and in the neurodegenerative trajectories seen in
the aging process.
In another paper that discusses the functional inter-
face between neuronal and endocrine systems during the
aging process, A. M. Stranahan et al. investigate the eﬀect
of two well-characterized antiaging interventions (caloric
restriction or exercise) upon hypothalamic function. The
hypothalamus forms a vital bridge between higher neuronal
activity and the status of the peripheral endocrine hormone
system. Age-related changes in hypothalamic activity appear
to be strongly connected to both endocrine and neuronal
pathophysiological mechanisms. A. M. Stranahan et al.
employ both caloric restriction and voluntary wheel running
paradigms in diabetic and nondiabetic animals to investigate
the contextual sensitivity of hypothalamic transcriptomic
responses to these antiaging lifestyle strategies. The authors
found that caloric restriction and physical exercise were asso-
ciated with distinct hypothalamic transcriptional signatures
that diﬀered significantly between the host physiological
contexts of the diabetic or nondiabetic mice.
In conclusion, our understanding of endocrine func-
tion in aging is making great strides. Several timely top-
ics concerning endocrine function in aging were purpose-
fully included in this special issue. However, it is clear that
further eﬀorts are needed to gain a greater appreciation of
the mechanisms underlying endocrine alterations in aging,
which will aid the development of more eﬀective interven-
tions for the treatment of endocrine defects during the aging
process.
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